The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined the pros and cons of biomarker-based ...

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

STAMPEDE otherwise follows a line of randomized trials (e.g., MAST, TAXOMET, IMPROVE) that have failed to prove cancer ...

This article explores how cancer biomarkers improve early detection, guide treatments and predict outcomes to transform ...

Indian American biomedical researcher has reported novel biomarkers for colorectal, bladder, prostate, stomach and pancreatic ...

Lung cancer may be curable, depending on a number of factors, including your age, health, stage of cancer, and how it ...

Kazia Therapeutics (NASDAQ:KZIA) on Wednesday reported preliminary results from the first patient in its Phase 1b trial ...

The field of immunotherapy has transformed the landscape of cancer treatment, particularly with solid tumors, introducing newer modalities that promise more ...

It is called HUNK (acronym of Hormonally Upregulated Neu-associated Kinase) and it is a new biomarker for gastric cancer: it ...

Cizzle Bio, Inc., a biotechnology company pioneering innovative biomarker blood tests for early detection of lung and gastric ...

Uterine cancer incidence and mortality rates are projected to increase significantly through 2050, according to a study ...

The projections come as National Cancer Institute data notes an increase in uterine cancer cases and deaths over the past 30 years.